Manufacturing · New York, United States · 500 Employees
Funding Date | Round | Amount | Investors | |
---|---|---|---|---|
May 10, 2019 | Stock Issuance/Offering | $200M | - | |
May 10, 2019 | Debt | $210M | - | |
Apr 05, 2018 | Stock Issuance/Offering | $250M | Samsara BioCapital, L.P. | + 1 more ![]() |
$1B
Total Funding Amount
$200M
Most Recent Funding Amount
11
Number of Funding Rounds
Quarter | Revenue |
---|---|
'21 - Q1 | 261080000 |
'21 - Q2 | 261080000 |
Dec 14, 2018
ADVANZ PHARMA
Oct 31, 2017
Abcur
Nov 25, 2014
Correvio
Mar 30, 2014
Paralex
Nov 21, 2009
Pinnacle Biologics
Artesian Therapeutics
See More Acquisitions & Subsidiaries
Intercept Pharmaceuticals’s headquarters are in 10 Hudson Yards, Fl 37, New York City, New York, 10001, United States
Intercept Pharmaceuticals’s phone number is (646) 747-1000
Intercept Pharmaceuticals’s stock symbol is ICPT
Intercept Pharmaceuticals’s official website is www.interceptpharma.com
Intercept Pharmaceuticals’s revenue is $354 Million
Intercept Pharmaceuticals’s SIC: 28,283
Intercept Pharmaceuticals’s NAICS: 325414,32541
Intercept Pharmaceuticals has 500 employees
Intercept Pharmaceuticals is in the industry of: Manufacturing, Pharmaceuticals, Chemicals & Related Products
Intercept Pharmaceuticals's main competitors are: Acceleron Pharma, Atara Bio, Relypsa, GBT
Intercept Pharmaceuticals has acquired the companies: ADVANZ PHARMA, Abcur, Correvio, Paralex
The technologies that are used by Intercept Pharmaceuticals are: Microsoft Azure, Achievers, ASP.NET, SonicWALL
Intercept Pharmaceuticals's CEO is Jerome Durso
Intercept Pharmaceuticals's CFO is Andrew Saik